Search by Journal
- HOME
- > Search by Journal
- > Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Volume , Issue suppl.1 / 2007


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
Clinical pharmacy in response to social expectation Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2007. |
---|
![]() |
To provide chemotherapy safely Setsuko Anan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2007. |
---|
![]() |
The medical problems and future in Japan Isao Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2007. |
---|
![]() |
We talk about an anticancer drug as patients with progressive cancer Takashi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2007. |
---|
![]() |
It is ... from a diseased child and the settings of ... childhood cancer treatment to support the family Ryota Hosoya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2007. |
---|
![]() |
The present conditions of the anticancer drug exposure in our country Shinichi Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2007. |
---|
![]() |
Safe handling of Hazardous Medications-Implications for the Pharmacy and Oncology Practice James A.Jorgenson Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2007. |
---|
![]() |
CLINICAL ASPECTS OF PHARMACOGENETICS AND PHARMACOGENOMICS:PRESENT AND FUTURE Urs A.Meyer Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2007. |
---|
![]() |
Problems and adherence improvement measures at use of inhalant Kunio Dobashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2007. |
---|
![]() |
To offer medical care of the expensive pawn Tsuguya Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2007. |
---|
![]() |
A study on the construction of a prescription inspection, dispensing support system and sterile injectable mixture preparation, inspection support system using an electronic medical record 杉山正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2007. |
---|
![]() |
Establishment of the generic technology of the tailor maid formulation study support system by pharmacokinetics, the kinetic utilization Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2007. |
---|
![]() |
29-S1-1 Development and Challenges for Hospital Pharmacy in China Dakui Li Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2007. |
---|
![]() |
29-S1-2 The Roles of Korean Hospital Pharmacists in the 21st Century-Project for Becoming the Best Hospital Pharmacists in the Future- Kyoung Ho Park Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2007. |
---|
![]() |
29-S1-3 Great Challenges of Japanese Hospital Pharmacists to the 21st Century Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2007. |
---|
![]() |
Administration plan corresponding to the age changes of the 29-S2-1 pharmacokinetics Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2007. |
---|
![]() |
From the experience of the pharmacist specialized in elderly people in the 29-S2-2 United States ウォーン pole Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2007. |
---|
![]() |
Role ... of the pharmacist in the action ... pressure sore measures team of the 29-S2-3 Kunitachi longevity medical center pharmacy It is passed through old Masaru Den Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2007. |
---|
![]() |
Fur Matthew tical care to 29-S2-4 elderly people Yuki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2007. |
---|
![]() |
Fur Matthew tical care to 29-S2-5 elderly persons living at home Yoko Inukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2007. |
---|
![]() |
Management and medical treatment of 29-S3-1 elderly people hypertension Iwao Kuwajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2007. |
---|
![]() |
Management and pharmacotherapy of 29-S3-2 elderly people hyperlipidemia Hidenori Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2007. |
---|
![]() |
Management and pharmacotherapy of 29-S3-3 elderly people diabetes Hiroshi Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2007. |
---|
![]() |
Management and elderly people pharmacotherapy of 29-S3-4 chronic kidney disease (CKD) Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2007. |
---|
![]() |
Management and pharmacotherapy of 29-S3-5 elderly people respiratory disease Kunihiko Yoshimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2007. |
---|
![]() |
Invention to avoid problems and that of multidrug therapy in 29-S3-6 elderly people Autumn lower Masahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2007. |
---|
![]() |
5-FU plasma concentration measurement ... in action ... esophageal cancer chemoradiotherapy to patients individualization in the 29-S4-1 cancer chemotherapy Nakamura job 1, Hirai green 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2007. |
---|
![]() |
Application to the cancer therapy of the 29-S4-2 genetic analysis The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2007. |
---|
![]() |
PK/PD of the immunosuppressive drug to make use of for 29-S4-3 organ transplantation Ikuko Yano 1, 2, Kenichi Inui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2007. |
---|
![]() |
Action for early detection, the evasion of the adverse event with the 29-S4-4 anticancer drug Pond end Hiroaki, The Mishima one up, Uchida まやこ, Hiroyuki Watanabe, Masanori Sueyasu, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2007. |
---|
![]() |
Cooperation - of new action - ward of the 29-S4-5 cancer drug control instruction and the foreign instruction Masato Yonemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2007. |
---|
![]() |
We examine illness from the situation of the 29-S5-1 hospital pharmacist and think about cooperation, the way of the medicine medicine cooperation Koichi Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2007. |
---|
![]() |
From a viewpoint providing information about the 29-S5-2 psychological care to a citizen Yuki Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2007. |
---|
![]() |
29-S5-3 Or pharmacist can contribute to the equalizing of palliative medicine : From the standpoint of cooperation and hospital pharmacists and team medical practice 龍恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2007. |
---|
![]() |
Role of the pharmacist in the 29-S5-4 at-home psychological care 轡基治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2007. |
---|
![]() |
Awareness as the 29-S6-1 medical care person Toru Hashida, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2007. |
---|
![]() |
Training of the ability to respond to the heart of the 29-S6-2 patients Izumi Machida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2007. |
---|
![]() |
The communication technology that the 29-S6-3 healthcare setting overlooks Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2007. |
---|
![]() |
Communication education in the 29-S6-4 School of Medicine and the problems Toshihiko Kinoshita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2007. |
---|
![]() |
Induction ... of utilization and the portfolio evaluation of action ... graduate school long term training that we applied to a pharmacy education six years system in the 29-S7-1 university hospital Hiromi Okazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2007. |
---|
![]() |
Business training model core curriculum to regard as 29-S7-2 student Teruo Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2007. |
---|
![]() |
Having been understood using the check list of the model core curriculum for the hospital training (four weeks) in the 29-S7-3 municipal hospital Yoshihisa Takao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2007. |
---|
![]() |
With the method of the drugstore training corresponding to the 29-S7-4 business training model core curriculum Naoki Uemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2007. |
---|
![]() |
Exploring - to achievement of present conditions - model core curriculum of the 29-S7-5 family drugstore business training Atsuko Chikada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2007. |
---|
![]() |
Present conditions of role - this hospital which a pharmacist carries out for 29-S8-1 team approach in medical care and future problem - Shoichi Yamaga, Small piece Fumiyo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2007. |
---|
![]() |
Contribution - neurosurgery ward to a side effect evaluation and safety management in the 29-S8-2 cancer chemotherapy as a case - Old Takaaki Tawara, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2007. |
---|
![]() |
It is utilization ... of the physical condition flow check chart through a diet, excretion, sleep, the exercise by ... pharmacist with the role of the opening of an office pharmacist in the 29-S8-3 medical care Koji Osawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2007. |
---|
![]() |
Role of the pharmacist in the practice of the 29-S8-4 university hospital Yutaka Katayama next Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2007. |
---|
![]() |
Figure of a drugstore, the pharmacist from 29-S9-1 this Hisayuki Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2007. |
---|
![]() |
About 29-S9-2 treatment at home 岩月進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2007. |
---|
![]() |
The way of the drugstore pharmacist as the 29-S9-3 school teacher Kiyokazu Sone Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2007. |
---|
![]() |
Support and adherence of the 30-S1-1 "consciousness of disease" Iwata relation life Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2007. |
---|
![]() |
Role - of - ward pharmacist thinking about adherence in the 30-S1-2 psychiatric practice Kenji Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2007. |
---|
![]() |
With the role as the 30-S1-3 second opinion failure case - to - schizophrenia patient family Kimiko Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2007. |
---|
![]() |
On participating in 30-S1-4 panel discussion at the situation of the family Tokuo Uemori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2007. |
---|
![]() |
Mainly on 30-S2-1 resistant bacteria, nosocomial infection measures -MDRP and MRSA - Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2007. |
---|
![]() |
Switch therapy - in antibiotic chemical treatment - community-acquired pneumonia treatment from 30-S2-2 this Katsunori Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2007. |
---|
![]() |
So that ... antimicrobial agent TDM and the problems perform TDM from business of the 30-S2-3 pharmacy effectively? Toshimi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2007. |
---|
![]() |
The topic effective safe administration method of administration of ... antimicrobial agent method these days is ... from the viewpoint of 30-S2-4 dosage regimen Moat Seiji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2007. |
---|
![]() |
30-S3-1 infection control and specialized pharmacist Takeshi Hirayama, Masaichi Kuroyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2007. |
---|
![]() |
Infection control based on the 30-S3-2 evidence Toshi Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2007. |
---|
![]() |
30-S3-3 infection control and surveillance Sawa Akihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2007. |
---|
![]() |
Proper use of the disinfectant in the 30-S3-4 infection control and the problems Shigeharu Oie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2007. |
---|
![]() |
Systematization of the 30-S3-5 infection control and role of the pharmacist Tadashi Shiraishi, Yoshito Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2007. |
---|
![]() |
How do you evaluate the value of 30-S4-1 drug duties? Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2007. |
---|
![]() |
Practice example about the value evaluation of 30-S4-2 ward duties Yuki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2007. |
---|
![]() |
Practice example about the value evaluation of 30-S4-3 drugstore duties Miwako Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2007. |
---|
![]() |
Practice example of the pharmacist duties in the 30-S4-4 critical care center ICU Junko Minemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2007. |
---|
![]() |
Of the value evaluation of hospital in 30-S4-5 United States drug duties, actually 陳惠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2007. |
---|
![]() |
To ride out a storm of medical - system reform in 30-S5-1 health care overhaul and the 21st century; ... Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2007. |
---|
![]() |
From the situation of the 30-S5-2 University Norio Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2007. |
---|
![]() |
Importance of medical care and the clinical pharmacy that the 30-S5-3 nation finds Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2007. |
---|
![]() |
From the situation of the 30-S5-4 medicine manufacture industry Hiroshi Akimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2007. |
---|
![]() |
From the situation of the 30-S5-6 medical care journalism Minoru Numata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2007. |
---|
![]() |
Importance ... of ethic - liberal arts of the pharmacist Hirai green 1, Ken Hazama solstice 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2007. |
---|
![]() |
Liberal arts to make use of in the ethic training of the 30-S6-1 pharmacist Jun Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2007. |
---|
![]() |
30-S6-2 Compatibility of science and ethics in research drug treatment : Be required to pharmacist 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2007. |
---|
![]() |
Morals dilemma to come across by 30-S6-3 pharmacist duties Kazumi Kawamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2007. |
---|
![]() |
Outlook on ethic of the pharmacist tried on the site of the 30-S6-4 treatment at home Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2007. |
---|
![]() |
About postgraduate education of the 30-S7-1 future Osamu Matsuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2007. |
---|
![]() |
Postgraduate education in the 30-S7-2 six years system Hirotoshi Echizen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2007. |
---|
![]() |
30-S7-3 member of society postgraduate education Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2007. |
---|
![]() |
The postgraduate education that 30-S7-4 drug industry expects Teruo Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2007. |
---|
![]() |
The postgraduate education that the 30-S7-5 healthcare setting overlooks Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2007. |
---|
![]() |
The present conditions and problems by the pharmacotherapy of the 29-A2-10-1 mind neurological disease Daisuke Tashiro, Kazuya Ooi, Hiromi Sasaki, Akira Shirohata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
Likelihood of the pharmacist in the 29-A2-10-2 psychiatric practice 梅田賢太 1, Nobuko Todo 1, Kenichi Mishima 4, 末丸克矢 3, Katsunori Iwasaki 4, Hiroshi Araki positive 3, Michihiro Fujiwara 4, Shunichiro Ogawa 2, Naoto Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
Change ... of prescription investigation - five years in 29-A2-10-3 psychiatric hospitals Shigeru Nishijima, Tomoda Motoko, Mami Yuki child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
The way (through judgment hospitalization) of the pharmacist in the many types of job team in the 29-A2-10-4 law concerning medical observation It is looked at Atsushi Kawashima, Takuya Ishida, Arai just levator, Noriko Noborisaka, Emiko Murata, Sumiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
About change of the consumption of the antipsychotics in the 29-A2-10-5 this hospital Takeki Yamamoto, Keizo Morimoto, 北村諭思 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
About the association of smoking and sex differences in the use of 29-A2-10-6 atypical antipsychotic agents Yuko Inoue, Bomura Kayoko, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2007. |
---|
![]() |
Study on renal function degeneracy speed rating system doubling 29-A3-10-1 serum creatinine Noriko Takeuchi 1, Mika Tsuge 1, Ayano Kato 1, Takenoshita Minoru Eda 1, Emiko Iida 1, Yuko Tajima 1, Asako Terashima 1, Keita Kimura 2, Description of Hamano existence 2, Makoto Ogawa 2, Daiya Sakurada 1, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
Hypotensive effect of fenofibrate based on the 29-A3-10-2 home blood pressure measurement Satoshi Ishikawa 1, Taku Ohara 1, 2, Hiroki Kataoka 1, 花澤智大 1, Koji Tanaka 3, 芝宮拓 1, Rii Morito child 1, Takashi Asayama 2, Masahiro Kikutani 1, Takayoshi Okubo 2, 3, 戸恒和人 1, 2, Junichiro Hashimoto 2, 3, Jun Imai 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
In use of medical supplies in examination - absolute irritation phase about the effect that the ethical drug which used during 29-A3-10-3 pregnancy gives to fetuses - Bamboo blind Takashi 1, Yano reason Rika 1, Kudo sheath or 1, Chisato Kitayama 1, Yasushi Morimoto intellect 1, Ken Nakajima 2, Daiya Sakurada 1, Kenji Kushida 2, Atsuko Murashima 3, Michihiro Kitagawa 4, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
Construction of reporting system (PKDIC) of the pharmacokinetic change by the 29-A3-10-4 drug interaction Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
One discussion ... from an examination - insulin preparation freezing test about the storage method not to make 29-A3-13-1 insulin preparation freeze up Toshinari Asakura 1, Feeling field Hiroaki 2, Noriaki Yokou 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
29-A3-13-2 For efficiency of dispensing business by counting dispensing inspection support system introduced 土屋明美1, 福澤悦子1, 倉林豊1, 萩原正和1, 廣部英明2, 大村義人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2007. |
---|
![]() |
Problems and remedy of the living guidance of patients with diabetes in the 29-A3-13-3 psychopathic ward Hiroshi Shirai 1, Mari Kasahara 1, Katsusane Tsurutani 1, Makiko Honma 1, Dotani 1-saving, Takashi Oda child 1, Akiko Takeya 1, Chieko Itagaki 2, High circle Yuji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
It is the recognition of 619 pharmacists the present conditions of the home blood pressure measurement in 29-A3-13-4 this country Koji Tanaka 1, Taku Ohara 2, 3, Mitsuru Kobayashi 2, 4, Masaru Takahashi joy 5, Norio Takahashi 5, Takayoshi Okubo 1, 3, 真野少 6, Straight appearance spring Taro 7, Jun Imai 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
It is a preparation uniformity study the quality comparison of the forerunner, the generic drug of the 29-A3-13-5 clarithromycin dry syrup Takemoto Eri 1, Sachie Okada 1, New Kana Oka 1, Mayuko Hayashi 1, Tokuyama picture straight 1, Toshihiko Ishizaka 1, 2, Junji Mukai 1, 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
Scoring taking-related the quality comparison of the forerunner, the generic drug of the 29-A3-14-1 clarithromycin dry syrup: Sachie Okada 1, Takemoto Eri 1, New Kana Oka 1, Mayuko Hayashi 1, Tokuyama picture straight 1, Toshihiko Ishizaka 1, 2, Junji Mukai 1, 2, Takahiro Uchida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
Smart evaluation of the forerunner, the generic drug of the theophylline dry syrup with the 29-A3-14-2 taste sensor Chika Kumagai, Rika Umino, Rumi Kudo, Tokuyama picture life, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
Discussion from the hypoglycemia instruction to patients with team approach diabetes in the 29-A3-14-3 ethical pharmacy Masako Satake 1, Mitsuko Tanaka 1, 岩倉麻莉 1, Michiko Yoshizawa 1, Kazuyo Yasuda 1, 水野晃冶 1, Nishimura friend man 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2007. |
---|
![]() |
Investigation about the methylergometrine maleate which we used for 29-A3-14-4 after giving birth Hirokazu Yamashiro, Yoko Osawa, Yusuke Taki, Kusaka Toyoshi, 揚張真利子, Toshiaki Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Study on characteristics of the poor 29-A3-14-5 antihypertensive medications remedy compliance person and lifestyle Azusa Hara 1, 3, Takayoshi Okubo 2, 3, Masahiro Kikutani 1, Taku Ohara 1, 3, Koji Tanaka 2, Metoki Konin 1, 4, Megumi Utsuki 6, Takasuke Inoue 3, Takashi Asayama 3, Junichiro Hashimoto 2, 3, 戸恒和人 1, 3, Hiroshi Sato 3, 5, Jun Imai 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Analysis of the affector to give to pyocyanic resistance to be isolated than 29-B1-10-1 inpatients Jin Tsukamoto 1, 2, Masanobu Imamura 4, 岩尾岳洋 1, Toshiaki Nakamura 1, Yoko Muroi 2, Masao Tobita 3, Masanobu Yamashita 2, 3, Hiromichi Iwasaki 2, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Action to proper use of the vancomycin teicoplanin Arbekacin by the 29-B1-10-2 TDM Satoshi Yokoyama, Naho Maeda, Seiko Chinen, Yukiko Hu, Original field Kazumi, Midori Kadoi, Hiroko Ota, Yasuji Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Search ... of the proper dosage method by examination - MIC measurement and the PK/PD analysis of the efficacy for Pseudomonas aeruginosa of the 29-B1-10-3 antiMRSA medicine Arbekacin Takashi Yoshimoto 1, Shigeki Kishida 1, Keisuke Kitani 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Establishment and application of a lot of 29-B1-10-4 carbapenem system antimicrobial agent assay Yuji Kurihara 1, Junko Kitsu 1, Moat Seiji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2007. |
---|
![]() |
Significance of the 29-B1-10-5 vancomycin hydrochloride note (VCM) initial beginning of dosage less than 24 hours TDM enforcement Yoko Hayashi, Yasushi Taniguchi tree, Masaru Kawase period, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
29-B2-10-1 The use situation and problem of the linezolid in the giving alm university hospital 北村正樹, 加文字理江, 中島清江, 加藤潤一郎, 菊野史豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
29-B2-10-2 Efforts about the linezolid proper use by the ICT 正畠和美, 前田奈穂, 知念聖子, 胡由希子, 角井碧, 横山聡, 大田博子, 森田保司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
Evaluation of the action of the antimicrobial agent proper use in the 29-B2-10-3 convalescent rehabilitation ward Look at Narai Kei; 1, Kaoruko Aoki 2, Shinobu Sekine 1, Miwa Nitta 1, Yukimi Kawaguchi 1, Kishino Chikashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
Case study - by action - ICT conference of the antimicrobial agent proper use in the 29-B2-10-4 Kochi medical center Yuki Okazaki 1, Land tax officer climb charges 1, 服部暁昌 1, Takamitsu Ito 2, Yasuo Fukui 3, Valley tree Toshikatsu 4, Teruo Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
An attitude survey about the hand rough weather in the 29-B2-10-5 Imizu Municipal Hospital and choice of alcohol hand disinfectants Masayuki Wakita 1, Tomomi Hoshino 1, Hiromi Ito 2, Junko Satake 2, Koichi Nobata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2007. |
---|
![]() |
About the efficiency of on admission initial interview duties and subsequent one week follow duties by the 29-B2-13-1 pharmacist Shigeru Yamada tree 1, Hiromi Sakai 1, 1 which is related to Nomura, House village Mai 1, Kana Kato 1, 鳥山高伸 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
A case and the discussion that effects of the warfarin were reinforced by 29-B2-13-2 R-ESHAP therapy Koga eyes 1, Takaaki Suzuki 1, Amount of Ariyoshi example 1, Shingo Yamazaki 1, Kobayashi collar 1, Hiroaki Tanaka 2, Middle Tomoaki Seko 2, Hiroshi Nakamura justice 1, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
Pharmaceutical management of the bringing medicine by the on admission patients interview of the 29-B2-13-3 ward pharmacist Inou Kanako, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
The sleep in the 29-B2-13-4 circulatory organ ward patients and investigation about the drug 八島加八, Yoshimasa Naomi, Sei Hattori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
Contribution of the pharmacist in the treatment of vancomycin for 29-B2-13-5 Clostridium difficile-positive patients and metronidazole Blue Takaaki 1, Yuichi Muraki 1, Corner Rieko 1, Naomi Hamaguchi 1, 2, Takuya Iwamoto 1, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
29-B2-14-1 Involvement of palliative care team launch and pharmacist : That is initiated from the ward responsible pharmacist 小林加寿子, 鷲頭辛次, 市川瞳, 松本智子, 石崎てるみ, 香月亮, 鶴田英夫, 岡忠之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2007. |
---|
![]() |
Inspection of the effect evaluation in the pharmacotherapy of the 29-B2-14-2 diabetes education hospitalization Setsuko Tomioka, 平岡輝余子, Risako Yamamoto, Fumihiko Sato, History of Tamura enthusiast, 弘世貴久, 綿田裕孝, Ryuzo Kawamori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
Action to raise the specialized viewpoint of the 29-B2-14-3 pharmacist, and to contribute to team approach in medical care positively Yukari Ogawa, 井上倫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
The present conditions of pharmacist duties for the bringing medicine for 29-B2-14-4 inpatients management Tatsuya Arai, Keisuke Osawa, Akihiro Miyazawa, Masato Takamori, Akizuki chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
Difference in theophylline clearance in the 29-B4-10-1 age group Kenichi Manabe 1, Naoyuki Murakami 1, Makoto Tanaka 1, Naomi Kuroki 2, Yuki Ushio 1, Small thicket Makiko 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
29-B4-10-2 Impact of Tacrolimus after the Switch from Fluconazole to Voriconazole in Patients Receiving Allo-stem Cell Transplant 河添仁1, 3, 田中裕章1, 福岡憲泰1, 大西宏明2, 石田俊彦2, 滝口祥令3, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
Likelihood to biomarker of steroid weight loss, the secession based on the lymphocytes susceptibility of the endogenous cortisol in 29-B4-10-3 renal-transplant recipients Hiroki Takeuchi 1, Tadashi Matsuno mischief 3, Toshihiko Hirano 2, Katsuyama Kei greens child 2, Mari Yokota 1, Tiger stone Riyusuke 4, Kiyoshi Okuyama 4, 横山卓剛 3, Hirara Ichiro Sana 3, Kihara A 3, Konno law of nature 3, Jojima Maro 3 who praises it, 阿不都許庫尓米吉提 3, Yuki Nakamura 3, Hitoshi Iwamoto 3, Koichiro Hama 3, 葦澤龍人 3, Kayoko Senuma 1, 長尾桓 3, 畝崎榮 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2007. |
---|
![]() |
29-B4-10-4 The pharmacokinetic study of proper administration method of pazufloxacin mesylate in hemodialysis patients 古久保拓1, 和泉智1, 佐藤みのり1, 松永千春1, 根来早紀子1, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
Comparison - of the pharmacokinetics with pharmacokinetics - renal-transplant recipients of immunosuppressive drug mycophenolic acid in patients with 29-B4-10-5 systemic lupus erythematosus Tomomi Matsushita 1, 2, Takafumi Naito 2, 見野靖晃 1, 2, Kimiyoshi Hirano 2, Atsushi Otsuka 3, Tomoki Ushiyama 3, Seiichiro Osono 3, Akira Hishida 4, Yoshiyuki Kagawa 1, Junichi Kawakami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
Pharmacokinetics of injectable Ciprofloxacin in the 29-B4-10-6 patient on dialysis and the clinical response Hiroki Okawara 1, Tail bird Katsuya 1, 2, Masahiro Kobayashi 2, Yuko Taguchi 1, 2, Rumiko Kondo 2, Hajime Matsubara 2, Kazuo Yago 1, 2, 長場泰 3, Takashi Sakamoto up 3, 鎌田貢壽 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
About the action of the pharmacist in the 29-B4-13-1 chemotherapy department Shinji Takahashi 1, 2, Hiromi Sakai 1, 2, Akihiro Koyama 1, 2, Ayumu Ichimura 1, Kana Kato 1, Shigeru Yamada tree 1, Setsuo Utsunomiya 2, 鳥山高伸 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
With prevention of stomatitis in the 29-B4-13-2 cancer chemotherapy, actually Yasuko Aizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
Start the use of the medicine notebook as safety management - tool of the 29-B4-13-3 cancer chemotherapy; and ... Jun Hosoya 1, Tsuyoshi Kojima 1, Hiroko Okabe 1, Hiroshi Mashita 1, Masumi Watanabe 1, Yumi Negishi 1, Rieko Kawai 1, Mayumi Kobayashi 1, Junichi Tamura 1, Koichi Kojima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2007. |
---|
![]() |
Use fact-finding of the indomethacin spray for 29-B4-13-4 oral mucositis and effective evaluation Ikuko Shindo 1, Masato Honma 1, 2, Ebina court noble 1, Hiroyuki Hosono 1, 100 Kenji 1, 2, Yoshiharu Suzuki 1, 2, Yasuyuki Kanbayashi 1, Tree Yoshiyuki Sawa 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
Use of drug evaluation based on the viewpoint of the medical economics in the 29-B4-13-5 cancer chemotherapy Ikemi Yasuaki, Toru Hashida, 深津祥央, Ikuko Yano, Masahiro Ishizu, Toshiya Katsura, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
About the interview induction to all patients by the pharmacist in the 29-B4-14-1 outpatient department chemotherapy room Hiromi Sakai 1, 2, Shinji Takahashi 1, 2, Akihiro Koyama 1, 2, Ayumu Ichimura 1, Kana Kato 1, Shigeru Yamada tree 1, Setsuo Utsunomiya 2, 鳥山高伸 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
Evaluation - of the team activity based on the use of role - opioids preparation situation of the pharmacist in the 29-B4-14-2 pain relief team Akira Hotta Hiromi 1, 2, Mayumi Torimoto 2, Masayuki Miyazaki 2, Kazuhiro Ishikawa 2, Yukihiro Noda 2, 4, Yoshinori Hasegawa 3, Kazuki Nagasawa 1, 藤本貞毅 1, Toshitaka Nabeshima 2, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
Foreign cancer chemotherapy protocol management and application to a foreign cancer chemotherapy pass using 29-B4-14-3 Web Teruo Obata 1, Kazuhiko Nakayama 1, Sho Shimizu original 1, Takashi Masuno 1, Hiroyuki Akiba 1, 岩崎英久 1, Takao Kume 1, 櫻澤千世 1, Hiroyuki Horiguchi 1, Kazunori Ishii 1, Masayuki Tamura 1, Masatoshi Ishizaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
Examination about the metrics making of the 29-B4-14-4 anticancer drug regimen Takeshi Ihoroi, Akiko Kuwahara, Nao Ishida, 大樹璃実, Makimoto Hiroo, 西口工司, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2007. |
---|
![]() |
Examination of arthralgia in the 29-B4-14-5 Weekly Paclitaxel therapy and peripheral neuropathy Tomoki Yoshioka, Naoyuki Hirakata, Ball Shiro Shima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
Interaction of 29-C1-10-1 warfarin and the SSRI Kuni Isobe finally, Tomoko Matsunaga, Satoko Nakamura, Taku Okabe, Chiho Murakami, Kazutaka Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
It is the contribution of the excretory system transporter gastrointestinal absorption behavior of 29-C1-10-2 Coenzyme Q10 Akiko Ochiai 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Mitsuru Sugawara 3, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
Effect of UGT2B7*3 which gives it to the carvedilol pharmacokinetics of the 29-C1-10-3 Japanese healthy subject Tadashi Taguchi up 1, Mutsuko Honda 1, Wakako Toyota 1, 堀内威佐男 1, Takako Shimizu 1, Yuichiro Kayano 1, Seiya Hashimoto 1, 能澤孝 2, Hiroshi Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
The elucidation of absorption dynamics of the 29-C1-10-4 lutein and examination for the oxidation disorder depression effect Sato evening period 1, Shibuya Tomomi 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
Albuminous contribution in the liver transportation of the 29-C1-10-5 glycyrrhizic acid Tomoe mountain path child, The Oyanagi Tsu husband who congratulates it, Kenjiro Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2007. |
---|
![]() |
Safe examination of oral beclomethasone based on a blood level for intestinal acute graft-versus-host disease after the allograft in the 29-C1-13-1 hematopoietic organ disease Kaori Watanabe 1, Tadaaki Ito 2, Nasu Izumi 2, Yumiko Uchida 2, History of Hisashi Yamamoto 3, Shuichi Taniguchi 3, Tomoji Yoshiyama 1, Motoko Kanke 1, Masahiro Hayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
Effect of the nutrition index (serum albumin level, the ideal weight ratio) which gives it to the febrile neutropenia in 29-C1-13-2 cancer chemotherapy patients Kenji Taniguchi, Hiroaki Matsuda, Mukaihara Rika, Ryosuke Kawase, Hiroki Mase, Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
A side effect investigation of the cisplatin lipiodol suspension for the 29-C1-13-3 primary liver cancer and evaluation Kenji Miyazawa 1, 2, Seko mouth Noriko 1, Yuichi Muraki 1, Takuya Iwamoto 1, Hideaki Tanaka 3, Motoo Iwasa 3, Kenji Takei 3, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
Analysis about peripheral neuropathy and the background factor in patients who received paclitaxel carboplatin combination therapy of the 29-C1-13-4 gynecology Yu Murashima oneself child 1, 2, Hiroko Sugimoto 1, Takuya Iwamoto 1, Tsutomu Tabata 3, Norimasa Sagawa 3, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
Examination about the efficacy of the action of the pharmacist for peripheral neuropathy with the 29-C1-13-5 FOLFOX4 therapy and Ca and the Mg combination Yumiko Furuno 1, Sakie Kawahara 1, Storehouse Hiroshi Hara 2, Yoichiro Matsuo 2, Shinmura green 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
Action of the TS-1 patient compliance instruction for the safe cancer pharmacotherapy for the 29-C1-14-1 outpatient Hiromi Tanoe, Celebration Chikako, House Yongjia child, 慈幸麻里, Masahiko Kobayashi, Kazue Takahashi, 寺田智祐, Toru Hashida, Ikuko Yano, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2007. |
---|
![]() |
Analysis of the prescription support contents of the ward pharmacist for the 29-C1-14-2 cancer chemotherapy enforcement patients Winnow music Mayumi, Shinobu Hasebe, Hiromi Tamura, Tadaaki Ito, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
Examination of the factor affecting the hematotoxicity of 29-C1-14-3 gemcitabine Genei Shinya 1, Yasuhiko Ichida 1, 加藤裕芳 1, Atsushi Furuse 2, Fumio Itagaki 3, Koda good luck direct 3, Ichiji Endo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
Correlation of stage, response and prognosis in the 29-C1-14-4 esophageal cancer chemoradiotherapy Akiko Kuwahara 1, Mountain Hiroshi Morimoto 1, Makimoto Hiroo 1, 西口工司 1, Yagi Keiko 2, Tatsuya Okuno 3, 4, Teahouse Naoko Hara 3, 4, 三木生也 4, Takao Tamura 4, Hirai green 1, 3, Sakaeda Toshiyuki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
Role of gemcitabine of the 29-C1-14-5 breast cancer chemotherapy Daisuke 1 out of the moat, Ayumi Tokita 1, 高野尊行 1, Akira Nakamaru 1, 稲瀬實 1, Junya Oguma 2, Shoichi Oka 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
Effect of the phytosterol which gives it to 30-A2-13-1 P - glycoprotein and breast cancer resistance protein Hirai green, Tomohiro Nabekura, Takeshi Yamaki, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
Change of the P-glycoprotein expression with the food composition with the 30-A2-13-2 anticancer activity Kyoko Nakazawa, Tomohiro Nabekura, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2007. |
---|
![]() |
1 case of the individualization cancer chemotherapy of the IFL regimen chemotherapy based on 30-A2-13-3 UGT1A1 genetic polymorphism and the drug disposition kinetic Shigeru Tomiyama chapter 1, Masashi Fukunaga 1, 花田法久 2, Manabu Okumura 4, Tomomi Iwakiri 4, Muneaki Hidaka 4, Nao Setoguchi 4, Emi Ichihara 4, Kazuhiko Arimori 4, Rika Yoshimoto 3, Yoshihito Uchino 2, Chizuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
Ca2+ activation K+ channel gene expression in the 30-A2-13-4 human prostate cancer Satomi Niwa 1, 大矢進 1, Akira Ono Minoru 1, Yoshihiro Ojima 2, Shoichi Sasaki 2, Kenjiro Koori 2, Yuji Imaizumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
ABC transporter expression change by the 30-A2-13-5 small intestine ischemia reperfusion Jiro Ogura 1, Masanori Kobayashi 2, Shiro Itagaki 2, Tsuyoshi Hirano 2, Takeshi Iseki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
Interaction of MRP-mediated transportation and valproic acid in the 30-A2-14-1 human erythrocyte membrane and carbapenem antibiotics Hot-bath resort Yoshiko, Keiko Yamakawa, Eri Kimura, Hamada is rare in the summer, Junya Nagai, Mikihisa Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
Effect of the CYP3A5 genetic polymorphism which gives it to the blood level / dose ratio of the tacrolimus in the 30-A2-14-2 live donor liver transplant patients and consumption Yuichi Muraki 1, Masanobu Usui 2, It is 3 of Nakatani, Takuya Iwamoto 1, Isa place Hideji 2, Shinko Okuda 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
Expression of CYP3A in the 30-A2-14-3 DSS-induced ulcerative colitis model mouse and nuclear receptor change 早川由隆, Ryo Nomura, Kaori Endo, 高橋孟瑠, Yudai Toda, Rumi Takeda, Igarashi sincerity intellect, Kiyomi Ito, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2007. |
---|
![]() |
30-A2-14-4 Comparison of cortisol 6 β - hydroxylase activity by CYP3A4 and CYP3A5 高崎由樹子1, 有吉範高1, 2, 中村裕義2, 石井伊都子1, 北田光一1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
The extraction of the specific drug prescription patients using the 30-A3-09-1 clinical studies DB system and detection of the clinical test value abnormality Kubono Naoko, Yu Shibata joy, Yamakawa flower Akemi, History of moat male, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
Comparison between the preparation by the PK analysis of the 30-A3-09-2 tulobuterol patch Tetsuo Watanabe 1, Akiko Miki 2, Moat foster child 2, Juichi Otani 2, Yasufumi Sawada 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
Expression of "the contraindication of the 30-A3-09-3 attachment document about kidney" and examination of the contraindicated drug use actual situation Finished river Satomi, Mika Kano, Seiki Koba, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
The need of the pharmacist intervention for the metildigoxin initial dose to 30-A3-09-4 elderly people Keiko Kobayashi, Yasuhiro Tsuji, Shinnichi Sado, Sone book Emi, Naoyuki Hirakata, Ball Shiro Shima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
Practice of the injection enforcement support task in the 30-A3-09-5 ward 林太祐, Maiko Karube, Yamada fine weather period, Kazuo Hattori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2007. |
---|
![]() |
Examination of 30-A3-13-1 quinolone antimicrobial hypersensitivity Manabu Abe 1, Yagi Motohiro 2, Katsuji Uno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
Relation ... to nausea and vomiting measures in participation in planning - chemotherapy to the medical treatment of the 30-A3-13-2 pharmacist Hiroko Shinoda, Upper mound Tomoko, 有木宏宗, 坂上逸孝, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
Cause investigation of the acute cholecystitis in 30-A3-13-3 ICU, the CCU Ayumu Nozaki 1, Ito greens wave 1, Moat Maki 2, Ryuji Yamamoto 2, Masahiro Mizobuchi 2, Funatsu Atsushi 2, Tsunemi Kotaro 3, Tomoko Kobayashi 2, Hirokazu Nakanishi 1, Enjoji Yoshihisa 2, Toshio Kurihara 3, Shigeru Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
One case of no thrombocythaemia that 30-A3-13-4 isepamicin, levofloxacin, lomefloxacin was thought to be associated with Shigeru Takahashi Expo 1, Toshihiko Takeno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
Examination of 30-A3-13-5 synthesis cold preparation hypersensitivity Tomoyasu Furukawa 1, Yagi Motohiro 1, Manabu Abe 2, 斎藤幹央 2, Koike reason Expo 3, Katsuji Uno 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
Association of the ticlopidine-induced liver damage and CYP2B6 genetic polymorphism in the 30-A3-14-1 Japanese Amount of Ariyoshi example 1, Iga Yukako 2, Tsuyoshi Miura 1, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2007. |
---|
![]() |
Examination about the effect of the oral alkalinization agent on diarrhea at 30-A3-14-2 FOLFIRI-3 therapy enforcement Kaori Miyamoto 1, Yasutaka Nakamura 1, Noriko Hashimoto 1, 仲佐啓詳 1, Takako Nakamura 1, Akira Ishii 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 宮内英聡 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
The actual situation of the consultation about pregnancy and the medicine in the 30-A3-14-3 fetuses outpatient department Kumi Katori 1, Masato Honma 1, 2, Yasuyuki Kanbayashi 1, Hiroshi Hamada true 2, Hiroyuki Yoshikawa 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
Examination of hypersensitivity in the 30-A3-14-4 enzyme preparation 齊藤幹央 1, Tomoyasu Furukawa 2, Yagi Motohiro 2, Katsuji Uno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
A preparation and clinical evaluations of the lactoferrin component film agent for the purpose of coping to the disease in the 30-A3-14-5 oral cavity Kutsugi Emi 1, Willow Shinji sail 1, Aya Ichise 1, Hiromi Matsuda 1, Ichinokawa Yoshimi 2, Masateru Matsui 3, Keiko Yamaoka 3, Machiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
One case of the chronic schizophrenia that a symptom improved with sudden weight loss in 30-B1-13-1 short term 大岩眞二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
The case that became able to leave the hospital by switching to 30-B1-13-2 second generation medicine alone Junji Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2007. |
---|
![]() |
Problems ... due to patient compliance instruction - anosodiaphoria to a schizophrenia patient of the 30-B1-13-3 onset Water of small depth Sae Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
Relation of the pharmacist aiming at 30-B1-13-4 adherence improvement Isurugi Ikuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
Intervention case of the pharmacist to the schizophrenia patient who developed in 30-B1-13-5 minor Tomoko Honda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
An example of the patient compliance instruction for 30-B1-14-1 bipolar patients Koichi Sato, Takashi Yoshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
Relation to patients with depression who had the 30-B1-14-2 alcohol disorder Kenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
Medication support to a case forced to frequent change of prescription by by the side effect of 30-B1-14-3 antidepressants Nakamura Sui child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2007. |
---|
![]() |
Action of the pharmacist that we maintain the patient compliance instruction to patients with 30-B1-14-4 mood disorders Taki Toshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Intervention to the prescription of patients with dementia to repeat 30-B1-15-1 fall Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Action to improvement of the substance abuse in patients with 30-B1-15-2 stimulant sequelae Miki Sonoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Example - that we felt the difficulty of being concerned with patients with patient compliance instruction - personality disorder to patients with 30-B1-15-3 borderline personality disorder Imperial garden Kazuko 1, 2, Kimiko Matsuda 1, Hara wide Ichiro 2, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Relation with the patients with the 30-B1-15-4 personality disorder-like symptom Kimiko Matsuda 1, Kunihiko Asai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Perform meeting a demand of a prescription from 30-B1-15-5 psychiatry; and with patients in ... health insurance pharmacy is concerned; ... Masaru Sasahara life Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2007. |
---|
![]() |
Enforcement of the use of antiMRSA medicine report system in the 30-B2-09-1 this hospital 濱野公俊 1, 2, 坂上逸孝 1, Haruna Sugimura 1, Mieko Yokoyama 1, Tanaka ratio dew beauty 2, Haruko Takasaki 2, 3, Taeko Takagi 2, 4, Hidefumi Shimodaira 5, Hiroshi Takemura 2, 6, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
About liver dysfunction by the ticlopidine remedy after the 30-B2-09-2 cipher stent placement Yusuke Taki 1, Hirokazu Yamashiro 1, Kusaka Toyoshi 1, Yoko Osawa 1, 揚張真利子 1, Toshiaki Kitagawa 1, Yuji Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
Investigation of an effect, the side effect in the 30-B2-09-3 amiodarone doses change patients Yoshie Araki, Hiromi Iura, Hiroko Enota, Yoshie Nishiyama, Tomoko Shibata, Tomoko Yanagisawa, Hiromi Nagai, Kayoko Kikuchi, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
Follow-up and discussion of patients receiving carvedilol for the 30-B2-09-4 chronic heart failure Yasushi Takai 1, Takeki Kajima 1, Hideo Nishikawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
The actual situation and the way of a sleeping drug, the tranquilizer administration in patients with 30-B2-09-5 rheumatism associated diseases Kiyomi Sadamoto, Mizuho Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
Examination of the palatability of the alendronate once a week preparation in patients with 30-B2-13-1 rheumatic disease Izumi Shimada 1, Ikuko Tanaka 2, 玉置繁憲 3, Takako Yamauchi 1, Kazuko Koyama 1, Hiroki Mase 1, Koike former 1, Takeshi Noro 1, Suzuki Suehiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2007. |
---|
![]() |
Construction of the medical safe drug transportation system based on 30-B2-13-2 BSC theory Toshiyuki Onishi, Marie Nakamoto, Shingo Nakamura, Tomoko Higashiyama, 3, Nakayama Hayao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
Examination of the activity of the future pharmacist judging from the use situation of the antibiotics for the 30-B2-13-3 injection Mitsuru Sugiura 1, 2, 3, 4, Daisuke Kameshima 1, Yoichi Kondo 1, Sugawara sheath or 1, Daichi Shibata 1, 増岡勝悟 1, 足立守 1, Makoto Ito 4, Masaru Iwata 3, Yoshio Asano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
About management, the handling of the gemeprost vagina suppository in the 30-B2-13-4 this hospital Field Takefu, Seiichi Sugimura, Osamu Kiyama, Noriko Suzuki, Kaoru Suzuki, Masami Nishihara, Hiroshi Tamai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
Construction (the second report) of the ward drug duties system in the 30-B2-13-5 Osaka medical center Naoki Hayakawa, Takeshi Kuwahara, Yoshiko Fukuda, 梅原玲緒奈, 村田真依, Yuka Nakamoto, Akiko Kamiya, Maiko Naito, Toya Aiko, Hirokazu Kamata, Kozo Tatsumi, Michi Miyata, Aya Kajita, Miki Ota, Person of sea Akiko, Sanae Wataya, Makoto Saito, Takashi Maekawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
A change permission system to generic medicine by the 30-B2-14-1 prescription order and the operation situation Shinji Kawai 1, Toshitaka Fukai 1, Osamu Ogino 3, Mitsuru Sugawara 1, Sakurai Kotaro 2, Takeshi Iseki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
It is ... for the skill up of team approach in medical care (medicine medicine cooperation) - pharmacist by 30-B2-14-2 hospital pharmacist and the ethical pharmacy pharmacist and medical quality improvement Kana Kato 1, 2, 3, Hiromi Sakai 1, Ayumu Ichimura 1, Takako Nakajima 1, Akihiro Koyama 1, 1 which is related to Nomura, Shinji Takahashi 1, Yuichiro Wada 1, Yoichi Sakakibara 1, Shigeru Yamada tree 1, 鳥山高伸 2, Miyaji Izumi 3, Takahiro Iida 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2007. |
---|
![]() |
We examine inside the hospital, illness in the 30-B2-14-3 diabetes patient education, and medicine medicine cooperation is established Junko Onishi 1, 3, Mariko Miwa 1, Yoko Hiramatsu 1, 占部彌昌 1, Eriko Suyama 1, Murakami Kazuharu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
Construction of the inhalational instruction system by the 30-B2-14-4 medicine medicine cooperation Keiko Kitajima 1, Prince Taniguchi chapter 1, 藤井宏透 2, 益永紀子 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
An investigation and evaluation of progress, the improvement situation of the investigational enforcement, base maintenance of the 30-B2-14-5 whole country institution Masakazu Yamaguchi 1, Yoichi Ishikawa 2, Kenji Kushida 2, Hidefumi Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
Memory retention augmentation effect by the 30-B3-09-1 angiotensin-converting enzyme inhibitor Sachiko Kanazawa, Descent from a mountain Ritsuko, Kazuhiro Hosoi, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
Examination of the efficacy of the Yokukansan for BPSD of 30-B3-09-2 dementia Noriko Takeda 1, 濱邊秋芳 1, Aiko Yokoyama 2, Chieko Yamaguchi 2, Kohei Toyomura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
Examination of efficacy of the clopidogrel administration for the 30-B3-09-3 PCI enforcement case sulfate and the tolerability Yutaka Yamazaki boatman, Naoya Ashikawa, Tadashi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2007. |
---|
![]() |
Effect of CGRP doses on 30-B3-09-4 septic shock model mouse Tsu storehouse Yuri, Yuko Takahata, Italy ヶ 崎由香, Daisuke Sasaki, Osamu Nakao incense, Takashi Kato children, Yoshio Ijiri, Kazuhiko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
30-B3-09-5 Study on calcineurin inhibitor sensitivity of peripheral blood mononuclear cells in myasthenia gravis patients 中島佳奈子1, 田中祥子1, 斎藤豊和2, 若田宣雄3, 平野俊彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
The present conditions of the substitute compounding of medicines with the 30-B3-13-1 generic drug Yasuhiro Sugiyama 1, Miyashita quiet 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
About the proper use of the 30-B3-13-2 antimicrobial agent from the situation of - risk management - Hiroko Ota, Naho Maeda, Seiko Chinen, Original field Kazumi, Yukiko Hu, Midori Kadoi, Satoshi Yokoyama, Mikami Historical Memoirs, Furutsuki Masako, Yasuji Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
The future prospects of the doubt inquiry as 30-B3-13-3 drug safety management duties Yoko Watanabe 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
Examination of the inspection method in 30-B3-13-4 anticancer drug preparation duties Makoto Nakajima, Akira Takahashi, Takuya Goto, Yoshie Nomura, Yumi Suzuki, Kimio Wakabayashi, 加藤浩充, Shuichi Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2007. |
---|
![]() |
Effect of preventive measures against dispensing errors which are main by 30-B3-13-5 ID number check 片倉道啓, Job field Takashi, Kikuko Oki, Country book Yusuke, Kazuya Takahashi, Katsuyuki Nakamura, Noriko Araya, Michiko Fujimori, 舩山幹男, Keiichi Okahara, Hiroshi Nakata is elegant, Rev. Noda plus, 鳥本勝, Atsushi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
Calculation - of the fact-finding - last inspection oversight rate of the 30-B3-14-1 cold water re-hat and dispensing error Hashimoto positive 1, Swamp part Kimiko 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
Examination of risk factor of delirium in the 30-B3-14-2 acute phase hospital Tomoko Nishiguchi 1, Hideko Kamikawa 2, Hiroki Osato 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
About the case that a change of the 30-B3-14-3 hospitalization environment controlled nutritional status Masaru Kawase period, Yasushi Taniguchi tree, Yoko Hayashi, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
It is ... through ... Oita Hospital Pharmacist Association infusion of nutrient workshop for the knowledge improvement about the nutrition care of the 30-B3-14-4 pharmacist Hiroko Abe 1, Hiroki Ito 2, Makoto Inoue 2, North Britain person 3, Hiromi Someya 1, Shoji Takeyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
30-B3-14-5 Effect to give to the immunocompetence of the fatty acid of ω-3 origin 岩瀬晴信1, 仮屋薗博子2, 池田龍二3, 有馬純子3, 藤崎裕子3, 重永明恵3, 石塚洋一5, 山田勝士3, 4, 中村和男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2007. |
---|
![]() |
Examination about a clinical response and the safety of the 30-B4-09-1 pravastatin preparation generic medicine Thin Masato, Makoto Hayashi, Koji Abe, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
Epidemiological survey of hyperuricaemia that is a side effect of Pyrazinamide to use for intensive therapy in 30-B4-09-2 tuberculosis short term Waterfall Hisashi 1, Kenji Ogawa 2, Hiroki Mase 3, Takeshi Noro 3, 野秋清聖 4, Fumihiko Sato 4, Katsunori Tabuchi 5, Hiroshi Funaki 1, 堀部千治 1, Tatsuya Murakami 6, 二改俊章 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
Examination of the utility of the biapenem pancreas local site intraarterial injection treatment for the 30-B4-09-3 severe acute pancreatitis Masaaki Watanabe 1, Yukihiro Hamada 2, Hiroshi Imaizumi 3, Yuko Taguchi 1, 2, Tail bird Katsuya 1, 2, Hiroshi Nishimaki 4, 西元寺克禮 3, Hajime Matsubara 2, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
Examination of the natto intake as the 30-B4-09-4 metabolic syndrome prevention 守内匡 1, 高田加壽代 1, Satomi Asano 1, Osamu Tanaka 1, Hiromi Matsui 1, Yoshimi Matsuda 1, Yutaka Takehara 1, Sachiko Hori 2, Yoshie Yamada 2, Main village Hisako 2, Ikuo Kanemoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
Examination about the gastric-acid secretion depressant drug combination at the oral chalybeate administration for 30-B4-09-5 iron-deficiency anemia Keiko Miyakawa, Makoto Hayashi, Koji Abe, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
Activity of the pharmacist by the disaster relief of the 30-B4-13-1 Noto Peninsula earthquake Masami Kawahara, 東敬一朗, Katsuhiko Nagase, Yusuke Hara, Kazuki Takeda, Daizo Maeda, Hiroko Okawa, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2007. |
---|
![]() |
About a discharge adjustment in the promotion of the 30-B4-13-2 treatment at home - medical institution and cooperation - of the drugstore Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
Examination of the cost effectiveness of the 30-B4-13-3 HMG-CoA reductase inhibitor Tatsuya Oda, Hoshina walnut, Takashi Yokoyama example, Tatsuya Kawai, Hideyuki Takahashi, Tadashi Tsuda University, Hiroshi Aoyama, Kenichi Sakamoto, Hideji Ohara, Hiroaki Watanabe, Katsuji Oura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
Problems and action about the posterior input slip at the 30-B4-13-4 hospitalization order ring Maze Hisanori 1, 林千麗 1, 舛永佳代子 1, 1, Asuka, Nagao, Rie Miyakawa 1, Miki Nakai 1, 須山奈見子 1, Yasushi Ishida Satoko 1, Koda sweetfish beauty 1, Mihoko Mori 1, Takeshi Suematsu 1, Hiroko Sugimoto 1, Nagasaka tomorrow or 1, Yagi Hideo 2, Yoshiharu Tsukamoto 3, Shun Otsuki intellect 4, Ota fence Masashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
Research about 30-B4-13-5 type II diabetes mellitus association drug costs Mihoko Tesaki 1, Aya Fujinami 2, Koji Hasegawa 1, Saori Michishita 1, 向誠一郎 1, Hitoshi Okugawa 3, Michiko Hayakawa 4, Kenzo Ishihara 5, Mitsuhiro Ota 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
About stability in the simple suspension of 30-C1-09-1 temozolomide Toshiko Aramiya 1, Yuka Kobayashi 1, Yuki Mikami 1, Masako Yoshimura 1, Hirokazu Nakanishi 1, Shinya Nakanishi 2, Kazuki Nagasawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
Examination about the injection method of temozolomide aiming at the compliance improvement of patients with 30-C1-09-2 children brain tumor Tomoyuki Mizuno 1, 2, Old Takaaki Tawara 1, Hiromi Tanoe 1, Toru Hashida 1, Ikuko Yano 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2007. |
---|
![]() |
Use experience of the 30-C1-09-3 F seal Minoru Kurihara man 1, Fujiwara season Yoshiko 2, Hachiya Tomomi 3, Setsuko Anan 4, Miki Inoue 4, Chika Fujii 4, Misako Fujino 4, Yukako Yasui 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
Evaluation of the new inactivating processor of the medical waste fluid including the 30-C1-09-4 antineoplastic 1, Toyofusa, Kobayashi, 2, Jun Hirose 2, 3, Koichi Sano 2, 4, Hironao tree 3, Hiroshi Tamai 1, 2, Hiroshi Takenaka 2, Takashi Nakano 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
Utility of anticancer drug sensitivity testing (MTTassay) for 30-C1-09-5 carcinomatous peritonitis, the pleurisy 杵崎正典, Kiyo Mizukami light, Eitaro Nakatsuka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
Trial of evaluation tool making and the training evaluation based on the 30-C1-13-1 business training model core curriculum evaluation plan Kazuko Kubo 1, Yoko Moriyasu 1, 中本行宣 1, Izushi Keiji 2, Takashi Shibata 3, Kazutaka Makino 3, Daisuke Teshima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
It is ... mainly on 30-C1-13-2 business training model core curriculum "action ... evaluation of the injection compounding of medicines" Keiko Hara 1, 2, Yumi Kimura 1, 才津恵 1, Yukako Ikeda 1, Noriko Kasahara 1, Harumi Harano 1, 大塚識稔 1, Eiji Sato 2, Seiji Eto 2, Hironori Yoshitomi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
A construction and the trial second of the 30-C1-13-3 business training system of administration Daiya Sakurada 1, Noriko Kobayashi 2, Asako Terashima 2, Yoshiko Miyazaki 3, Tadao Inoue 4, Shigekazu Watanabe 5, 6, Ichiji Endo 7, Noboru Sato example 1, Shiro Ueda 1, Junko Kitsu 2, Toshiji Horie 1, Masataka Mochizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2007. |
---|
![]() |
The use of the Internet search engine in the 30-C1-13-4 six years system pharmacy education Osamu Fujishita 1, Calis Karim2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|
![]() |
30-C1-13-5 evaluates the use of "e-Learning for OTC medicine proper use" Tsukiji jasmin child, Minae Izawa, Noriko Kose, 崔吉道, Emi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|
![]() |
We think about "throb training to be heated to be heated" in the 30-C1-14-1 Iida Hospital Masafumi Kinoshita, Light Risa Sawa child, Hiroko Matsumura, Kozue Okada, 林宜生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|
![]() |
Training contents evaluation research by the person of institution investigation about training contents in the pharmacist training specialized in 30-C1-14-2 cancer and training Koji Murakoshi, 牧野好倫, Hirohisa Kato, Taisuke Hojo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|
![]() |
Action of the TDM duties induction promotion in the cottage-hospital in 30-C1-14-3 Kanagawa Toishima study 1, 2, Koji Fujimoto 1, Jun Inoue Expo 1, 1, Kotobuki, Sekine 1, Yuko Komura 1, Kawaguchi three major cities child 1, Kenji Saito 1, 嶋崎眞義 1, Yukiko Nakamura 1, Katsunori Hattori 1, Ayako Yamaura 1, Izumi Yoshida 1, Masayuki Morita 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|
![]() |
The change and the present conditions of the pharmacist duties in the 30-C1-14-4 capital municipal hospital Mikio Hayashi 1, 2, Tatsuo Tanaka 2, 3, Michio Usui 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2007. |
---|